Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030)
Clinical trial NCT02661126 · COMPLETED
Trial details
- NCT number
- NCT02661126
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-19
- Primary completion
- 2016-08-26
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.